📖 Education

🎓 Degree

• Ph.D. of Biology, 2022-2028 (expected), School of Basic Medical Sciences, Fudan University, Shanghai, China

  • Major: Metabolism and Diseases, Biochemistry and Molecular Biology
  • Programme: Successive postgraduate and doctoral programme
  • Research interests: Cancer Research; Bioinformatics; Human Microbiome
  • Academic advisor: Dr. Zhao Zhang

• B.Sc. of Biology, 2016-2021, College of Informatics, Huazhong Agricultural University, Wuhan, China

  • Major: Bioinformatics
  • Graduation project: Benchmarking imputation algorithms in scRNA-seq analysis
  • Academic advisor: Dr. Qianqian Shi

🏛️ Visiting and exchanging

• Visiting Student, 2025, School of Life Science, Fudan University, Shanghai, China

  • Programme:
    • Genetics and Developmental Biology
    • Evolutionary and Biological Big Data
  • Oral presentation topic:
    • Intratumour microbiome in gastric cancer (The First Prize)
    • bacNeo: a computational toolkit for bacteria-derived neoantigen identification (The Second Prize)

• Visiting Student, 2019, School of Life Science, The Chinese University of Hong Kong, Hong Kong, China

  • Programme: Biological and Biomedical Science Programme
  • Research topic: The mechanism and clinical applications of siRNAs

📑 Publication

Marks: Co-first author† and corresponding author#.

• As the first and co-first author
  • Wang Y., …, Zhang Z.#, & Han L.# Characterization of Tumor Antigens from Multi-omics Data: Computational Approaches and Resources. Genomics, Proteomics & Bioinformatics qzaf001 (2025).
  • Yuan L.†, Pan L.†, Wang Y.†, …, Zhang Z.#, & Cheng X.# Characterization of the landscape of the intratumoral microbiota reveals that Streptococcus anginosus increases the risk of gastric cancer initiation and progression. Cell Discov 10, 117 (2024).
  • Wang Y., …, & Zhang Z.# Enhancer RNA (eRNA) in Human Diseases. Int. J. Mol. Sci. 23, 11582 (2022).
• As contributing author
  • Zhang C.†, Chen Y.†, Chen S., Wang Y., …, & Zhang Z.# Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer. Cancer Res 3, 85 (2025).